Internal medicine

Pathology

Sociology

Business

Panel discussion

Social science

Family medicine

Politics

Advertising

Oncology

Political science

Intensive care medicine

Multidisciplinary approach

Medical physics

Lung cancer

MEDLINE

Guideline

Consensus conference

Voting

Clinical trial

Medicine

Annals of Oncology

The European Society for Medical Oncology (ESMO) held a virtual consensus-building process on epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer in 2021. The consensus included a multidisciplinary panel of 34 leading experts in the management of lung cancer. The aim of the consensus was to develop recommendations on topics that are not covered in detail in the current ESMO Clinical Practice Guideline and where the available evidence is either limited or conflicting. The main topics identified for discussion were: (i) tissue and biomarkers analyses; (ii) early and locally advanced disease; (iii) metastatic disease and (iv) clinical trial design, patient’s perspective and miscellaneous.

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer